WHO ICTRP trial
Phase I Dose Escalation Study of Clofarabine and Liposomal Daunorubicin in…
EUCTR2008-002288-14-GB · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2008-002288-14-GB |
|---|---|
| Public title | Phase I Dose Escalation Study of Clofarabine and Liposomal Daunorubicin in Childhood and Adolescent AML - CLOUD |
| Scientific title | Phase I Dose Escalation Study of Clofarabine and Liposomal Daunorubicin in Childhood and Adolescent AML - CLOUD |
| Primary sponsor | University of Birmingham |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): no |
| Countries | United Kingdom |
| Conditions | Paediatric patients (6 months to 18 years) diagnosed with AML who are refractory to front line therapy, early first relapse (less than 1 year from diagnosis) and second and subsequent relapse patients. MedDRA version: 9.1 Level: LLT… |
| Interventions | Trade Name: DaunoXome injection (liposomal daunorubicin) Product Name: DaunoXome Pharmaceutical Form: Intravenous infusion INN or Proposed INN: DAUNORUBICIN CAS Number: 20830813 Concentration unit: mg/ml milligram(s)/millilitre… |
| Registration date | Oct 31, 2008 |
| Target size | 18 |
| Secondary IDs | HM1006 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- Yes Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: